Company announcements: Biosensors, ChinaPrtP

Biosensors - ANNOUNCEMENT OF CESSATION AS NON-EXECUTIVE NON-INDEPENDENT DIRECTOR - MS PHYLLIS CHAN YUK YING

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: BIOSENSORS INT'L GROUP, LTD.
Stock Code/Name: B20 - Biosensors

ANNOUNCEMENT OF CESSATION AS NON-EXECUTIVE NON-INDEPENDENT DIRECTOR - MS PHYLLIS CHAN YUK YING * Asterisks denote mandatory information Name of Announcer * BIOSENSORS INT'L GROUP, LTD. Company Registration No. EC 24983 Announcement submitted on behalf of BIOSENSORS INT'L GROUP, LTD. Announcement is submitted with respect to * BIOSENSORS INT'L GROUP, LTD. Announcement is submitted by * RONALD EDE Designation * CFO/ COMPANY SECRETARY Date & Time of Broadcast 29-Jan-2014 17:42:54 Announcement No. 00107   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Name of person * Phyllis Chan Yuk Ying Age * 53 Is Effective Date of Cessation known? * Yes If yes, please provide the date * 29/01/2014 Detailed Reason(s) for cessation * Ms Phyllis Chan was nominated by Shandong Weigao Group Medical Polymer Company Limited (Shandong Weigao) which owns 100% of Wellford Capital Limited (Wellford), a controlling shareholder of the Company. Consequent to the cessation of Wellford as the controlling shareholder of the Company, Ms Chan shall also step down as a director of the Company. Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No If yes, please elaborate * NA Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No If yes, please elaborate * NA Any other relevant information to be provided to shareholders of the listed issuer? * No If yes, please elaborate * NA Date of Appointment to current position * 27/11/2012 Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Non-Executive Non-Independent Director Role and responsibilities * Non-executive. Does the AC have a minimum of 3 members (taking into account this cessation)? * Yes Number of Independent Directors currently resident in Singapore (taking into account this cessation) * 3 Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months * 2 Interest * in the listed issuer and its subsidiaries * 11,000 options of Biosensors International Group, Ltd. Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * None.   >> OTHER DIRECTORSHIPS Past (for the last 5 years) * None. Present * Gain Label Limited. Footnotes Attachments Total size = 0K (2048K size limit recommended)

---

Biosensors - ANNOUNCEMENT OF CESSATION AS NON-EXECUTIVE NON-INDEPENDENT DIRECTOR - MR HUAWEI ZHANG

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: BIOSENSORS INT'L GROUP, LTD.
Stock Code/Name: B20 - Biosensors

ANNOUNCEMENT OF CESSATION AS NON-EXECUTIVE NON-INDEPENDENT DIRECTOR - MR HUAWEI ZHANG * Asterisks denote mandatory information Name of Announcer * BIOSENSORS INT'L GROUP, LTD. Company Registration No. EC 24983 Announcement submitted on behalf of BIOSENSORS INT'L GROUP, LTD. Announcement is submitted with respect to * BIOSENSORS INT'L GROUP, LTD. Announcement is submitted by * RONALD EDE Designation * CFO/ COMPANY SECRETARY Date & Time of Broadcast 29-Jan-2014 17:39:47 Announcement No. 00103   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Name of person * Huawei Zhang Age * 50 Is Effective Date of Cessation known? * Yes If yes, please provide the date * 29/01/2014 Detailed Reason(s) for cessation * Mr Zhang Huawei was nominated by Shandong Weigao Group Medical Polymer Company Limited (Shandong Weigao) which owns 100% of Wellford Capital Limited (Wellford), a controlling shareholder of the Company. Consequent to the cessation of Wellford as the controlling shareholder of the Company on 20 December 2013, Mr Zhang shall also step down as a director of the Company. Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No If yes, please elaborate * NA Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No If yes, please elaborate * NA Any other relevant information to be provided to shareholders of the listed issuer? * No If yes, please elaborate * NA Date of Appointment to current position * 03/10/2011 Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Non-Executive Non-Independent Director Role and responsibilities * Non-executive. Does the AC have a minimum of 3 members (taking into account this cessation)? * Yes Number of Independent Directors currently resident in Singapore (taking into account this cessation) * 3 Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months * 1 Interest * in the listed issuer and its subsidiaries * 66,000 options of Biosensors International Group, Ltd. Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * None   >> OTHER DIRECTORSHIPS Past (for the last 5 years) * 1. Wego Medical Holding Company Limited 2. (Medtronic Weigao Orthopaedic Devices Company Limited*) * For identification only. Present * 1. (Shandong Weigao Group Medical Polymer Company Limited*) 2. Weigao International Medical Company Limited 3. Wellford Capital Limited 4. (Shandong Gaosaide Technology Development Company Limited*) 5. (Shandong Weigao Medical Facilities Company Limited*) 6. (Weigao Holding Company Limited*) 7. (Weihai Weigao Housing Development Company Limited*) 8. (Weihai Jierui Medical Products Company Limited*) 9. ( Weihai Weigao Blood Purification Products Company Limited*) * For identification only. Footnotes Attachments Total size = 0K (2048K size limit recommended)

---

Biosensors - ANNOUNCEMENT OF APPOINTMENT OF CHIEF OPERATING OFFICER / EXECUTIVE DIRECTOR - MR QIANG JIANG

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: BIOSENSORS INT'L GROUP, LTD.
Stock Code/Name: B20 - Biosensors

ANNOUNCEMENT OF APPOINTMENT OF CHIEF OPERATING OFFICER / EXECUTIVE DIRECTOR - MR QIANG JIANG * Asterisks denote mandatory information Name of Announcer * BIOSENSORS INT'L GROUP, LTD. Company Registration No. EC 24983 Announcement submitted on behalf of BIOSENSORS INT'L GROUP, LTD. Announcement is submitted with respect to * BIOSENSORS INT'L GROUP, LTD. Announcement is submitted by * RONALD EDE Designation * CFO/ COMPANY SECRETARY Date & Time of Broadcast 29-Jan-2014 17:36:35 Announcement No. 00096   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Date of Appointment * 29/01/2014 Name of person * Qiang Jiang Age * 41 Country of principal residence * China The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * The Board has reviewed the qualifications, experiences and suitability of Mr Qiang Jiang and has approved the appointment of Mr Jiang as Chief Operating Officer. Mr Jiang will continue to serve as an Executive Director on the Board of Directors. Whether appointment is executive, and if so, the area of responsibility * Appointment is Executive. Mr Jiang will be responsible for the overall day-to-day operations of the Group. Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Executive Director/ Chief Operating Officer Working experience and occupation(s) during the past 10 years * Mr. Jiang Qiang joined the Biosensors board as a non-executive non-independent director on 3 October 2011. Mr. Jiang has an extensive experience in accounting and financial management. He is a former consultant of Shandong Weigao Group Medical Polymer Company Limited ("Shandong Weigao"). Prior to this, he served as the head of corporate strategy and the deputy general manager of Shandong Weigao until August 2011. Mr. Jiang obtained a master degree in Accounting from Northeast University of Finance and Economics in the People's Republic of China in 1998. Interest * in the listed issuer and its subsidiaries * 83,000 options of Biosensors International Group, Ltd. Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries * None. Conflict of interests (including any competing business) * None.   >> OTHER DIRECTORSHIP # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8). Past (for the last 5 years) 1. Wego Medical Holding Company Limited 2. Shandong Weigao Orthopaedic Materials Company Limited* 3. Medtronic Weigao Orthopaedic Devices Company Limited* 4. Weigao Holdidng Company Limited* 5. Weigao JW Medical Products Company Limited* 6. Weihai Weigao Blood Purification Products Company Limited* * For identification only Present 1. JW Medical Systems Limited 2. Best Prime Investment Limited   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H) Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given. (a)* Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No (b)* Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No (c)* Whether there is any unsatisfied judgment against him? No (d)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No (e)* Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No (f)* Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No (g)* Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No (h)* Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No (i)* Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No (j)* Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :- (i)* any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No (ii)* any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No (iii)* any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No (iv)* any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No (k)* Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No   >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(I) Disclosure applicable to the appointment of Director only. Any prior experience as a director of a listed company? Yes If yes, please provide details of prior experience. Non-Executive Non-Independent Director of Biosensors International Group, Ltd. since 3 October 2011. Footnotes Attachments Total size = 0K (2048K size limit recommended)

---

Biosensors - MISCELLANEOUS :: CHANGES TO THE BOARD AND BOARD COMMITTEES

Announcement Type: MISCELLANEOUS
Company: BIOSENSORS INT'L GROUP, LTD.
Stock Code/Name: B20 - Biosensors

MISCELLANEOUS :: CHANGES TO THE BOARD AND BOARD COMMITTEES * Asterisks denote mandatory information Name of Announcer * BIOSENSORS INT'L GROUP, LTD. Company Registration No. EC 24983 Announcement submitted on behalf of BIOSENSORS INT'L GROUP, LTD. Announcement is submitted with respect to * BIOSENSORS INT'L GROUP, LTD. Announcement is submitted by * RONALD EDE Designation * CFO/ COMPANY SECRETARY Date & Time of Broadcast 29-Jan-2014 17:31:00 Announcement No. 00088   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Announcement Title * CHANGES TO THE BOARD AND BOARD COMMITTEES Description Please refer to the attached announcement. Attachments 20140129_BIG_Board_Changes_Announcement.pdf Total size =176K (2048K size limit recommended)

---

ChinaPrtP - DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER

Announcement Type: DISCLOSURE OF INTEREST/CHANGES IN INTEREST
Company: CHINA PRINT POWER GROUP LTD
Stock Code/Name: B3C - ChinaPrtP

DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER * Asterisks denote mandatory information Name of Announcer * CHINA PRINT POWER GROUP LTD Company Registration No. N.A. Announcement submitted on behalf of CHINA PRINT POWER GROUP LTD Announcement is submitted with respect to * CHINA PRINT POWER GROUP LTD Announcement is submitted by * Tsui Kan Chun Designation * Joint Company Secretary Date & Time of Broadcast 29-Jan-2014 17:45:23 Announcement No. 00111   >> ANNOUNCEMENT DETAILS The details of the announcement start here ... Person(s) giving notice * Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1) Date of receipt of notice by Listed Issuer * 29/01/2014 Attachments CPPGL-Form1_SzeChunLee.pdf Total size =224K (2048K size limit recommended)

---